New Mexico Gov. Michelle Lujan Grisham (D) on Sunday blasted Republican efforts to reduce Medicaid funding, saying potential cuts would "destroy health care as we know it." "This is very simply an effort to destroy health care as we know it, to rip it away from everyday Americans, make it more costly for everybody else," Lujan Grisham said in an interview on CBS News's "Face the Nation." The Democratic governor warned that potential cuts would have far-reaching consequences across the country.
Imagine if every physician and nurse had a clinical partner as capable, knowledgeable and reliable as they are. Not a junior resident to supervise or a chatbot that summarizes notes, but an associate capable of solving novel problems, reasoning across specialties and making sound medical decisions 24/7 without burnout or bias. That day may be closer than most people expect.
While AI incites a range of feelings when it comes to its clinical implications and possibilities, I am much more focused on leveraging AI to solve healthcare's administrative challenges. Considering these burdens cost $600 billion to $1 trillion annually, AI offers a remarkable opportunity to increase efficiency, reduce waste, and deliver first-class experiences for everyone.
The partner of Theranos founder Elizabeth Holmes has raised millions of dollars for an artificial intelligence startup hoping to introduce a product that can be used in medical testing and other settings, according to two sources with direct knowledge of the endeavor who could not speak publicly because the company has not yet officially launched. The company is called Haemanthus, which is Greek for 'blood flower.'
House Republicans plan to enact work requirements and more frequent eligibility checks for Medicaid, according to a House Energy and Commerce Committee plan released late on May 11. However, the proposal does not pursue some of the deeper cuts that lawmakers had considered, including lowering the federal match rates with states or capping per-person federal spending in Medicaid.
Researchers at the University of California, San Diego School of Medicine have identified a potential new treatment for individuals with uncontrolled or treatment-resistant hypertension, a condition commonly referred to as high blood pressure. The investigational drug, lorundrostat, showed encouraging results in a recent clinical trial.